BTRX-335140

CAS : 2244614-14-8

Ref. 3D-UPD61414

Informations sur le produit

• Nom: BTRX-335140
• Synonymes: BTRX 331540, 1-(6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine, CYM 53093, 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-, 1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine

Description

BTRX-335140 is a novel compound that has been shown to modulate the opioid receptor. It is orally active and has a pharmacokinetic profile that is characterized by rapid absorption and elimination. The compound binds to the opioid receptor, modulating its activity. Electrophysiological studies have demonstrated that BTRX-335140 exhibits high affinity for the tegmental and ventral portions of the brain, but not the dorsal region. It also has been shown to act as an antagonist of dopamine receptors, which may contribute to some of its antidepressant effects.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 453.6 g/mol
• Formule: C₂₅H₃₂FN₅O₂
• Degré de pureté: Min. 95%